The blockage of the IFN-α/β receptor with monoclonal antibodies prevents diabetes in nonobese diabetic mice (10, 11), and the inhibition of IFN-α-mediated intracellular signaling in a model of β-cells prevents the overexpression of MHC I (12). Here, IFNA2 is linked to diabetes mellitus.